Orexigen (OREX), Takeda Sue Activis (ACT) Over Generic Contrave ANDA
Tweet Send to a Friend
Orexigen Therapeutics (NASDAQ: OREX) announced that it and its North American partner, Takeda Pharmaceuticals, have filed a lawsuit in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE